Safety and efficacy of imatinib in CML over a period of 10 years: data from the randomized CML-study IVLida Kalmanti, M. C. Muller, Christian Dietz et al.|Leukemia|2015Cited by 274
Impact of comorbidities on overall survival in patients with chronic myeloid leukemia: results of the randomized CML Study IVSusanne Saußele, Martin C. Müller, Marie-Paloma Krauß et al.|Blood|2015Cited by 200